The 9th Symposium “Advances in Cancer Immunology & Immunotherapy is an intensive”, three days interactive meeting during which all invited speakers will address the accumulated knowledge so far from the field of translational cancer research, clinical cancer research and clinical trials based on immunotherapy-guided strategies.
The scientific objectives of this program are focused on (a) biomarkers for predicting response to immunotherapeutic modalities in cancer management; (b) mechanisms of action for immunotherapeutic treatments in the treatment of malignancy; (c) data from clinical trials investigating the efficacy and safety of cancer immunotherapy regimens; and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events.
This year’s Conference will feature world-renowned oncologists and researchers who will provide their insights on the topics above in an effort to better understand tumor evolution and designing improved treatment strategies. Our Meeting will welcome scientists, clinicians, students and health care professionals interested in the field of Cancer Immunology and Immunotherapy to participate.
